Fermented <i>Morinda citrifolia</i> (Noni) Alleviates DNCB-Induced Atopic Dermatitis in NC/Nga Mice through Modulating Immune Balance and Skin Barrier Function

<i>Morinda citrifolia</i>, a fruit generally known as &#8220;Noni&#8221;, has been traditionally used in parts of East Asia to relieve inflammatory diseases. Although several studies using noni have been reported, the effect of fermented <i>Morinda citrifolia</i> (F.N...

Full description

Bibliographic Details
Main Authors: Sung Ho Kim, Geum Su Seong, Se Young Choung
Format: Article
Language:English
Published: MDPI AG 2020-01-01
Series:Nutrients
Subjects:
th1
th2
Online Access:https://www.mdpi.com/2072-6643/12/1/249
id doaj-afd611a26c284fe29c9c98aeaa168c72
record_format Article
spelling doaj-afd611a26c284fe29c9c98aeaa168c722020-11-25T01:10:11ZengMDPI AGNutrients2072-66432020-01-0112124910.3390/nu12010249nu12010249Fermented <i>Morinda citrifolia</i> (Noni) Alleviates DNCB-Induced Atopic Dermatitis in NC/Nga Mice through Modulating Immune Balance and Skin Barrier FunctionSung Ho Kim0Geum Su Seong1Se Young Choung2Department of Life and Nanopharmaceutical Sciences, Graduate School, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, KoreaKorea Food Research Institute, 245 Nongsaengmyeong-ro, Iseo-myeon, Wanju_Gun, Jeollabuk-do 55365, KoreaDepartment of Life and Nanopharmaceutical Sciences, Graduate School, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Korea<i>Morinda citrifolia</i>, a fruit generally known as &#8220;Noni&#8221;, has been traditionally used in parts of East Asia to relieve inflammatory diseases. Although several studies using noni have been reported, the effect of fermented <i>Morinda citrifolia</i> (F.NONI) on atopic dermatitis (AD) has not been investigated. Thus, we aimed to investigate the improving effect of F.NONI treatment on AD-like skin lesions and elucidate molecular mechanisms. F.NONI was prepared by the fermentation of noni fruit with probiotics and then extracted. F.NONI was orally administrated to NC/Nga mice to evaluate its therapeutic effect on 2,4-dinitrochlorobenzene (DNCB)-induced AD. Oral administration of F.NONI significantly alleviated AD lesions and symptoms such as dermatitis scores, ear thickness, scratching behavior, epidermal thickness, and infiltration of inflammatory cells (e.g., mast cells and eosinophils). In addition, F.NONI treatment reduced the levels of histamine, IgE and IgG1/IgG2a ratio, thymus and activation regulated chemokine (TARC), and thymic stromal lymphopoietin (TSLP) in serum and beneficially modulated the expressions of Th1, Th2, Th17, and Th22-mediated cytokines in lesioned skin and splenocytes. Furthermore, the expressions of the skin barrier-related proteins including filaggrin (FLG), loricrin (LOR), involucrin (IVL), zonula occludens-1 (ZO-1), and occludin (OCC) were restored by F.NONI treatment. Taken together, these results suggest that F.NONI could be a therapeutic agent to attenuate AD-like skin lesions through modulating the immune balance and skin barrier function.https://www.mdpi.com/2072-6643/12/1/249atopic dermatitisfermented morinda citrifolianc/ngath1th2immune balanceskin barrier function
collection DOAJ
language English
format Article
sources DOAJ
author Sung Ho Kim
Geum Su Seong
Se Young Choung
spellingShingle Sung Ho Kim
Geum Su Seong
Se Young Choung
Fermented <i>Morinda citrifolia</i> (Noni) Alleviates DNCB-Induced Atopic Dermatitis in NC/Nga Mice through Modulating Immune Balance and Skin Barrier Function
Nutrients
atopic dermatitis
fermented morinda citrifolia
nc/nga
th1
th2
immune balance
skin barrier function
author_facet Sung Ho Kim
Geum Su Seong
Se Young Choung
author_sort Sung Ho Kim
title Fermented <i>Morinda citrifolia</i> (Noni) Alleviates DNCB-Induced Atopic Dermatitis in NC/Nga Mice through Modulating Immune Balance and Skin Barrier Function
title_short Fermented <i>Morinda citrifolia</i> (Noni) Alleviates DNCB-Induced Atopic Dermatitis in NC/Nga Mice through Modulating Immune Balance and Skin Barrier Function
title_full Fermented <i>Morinda citrifolia</i> (Noni) Alleviates DNCB-Induced Atopic Dermatitis in NC/Nga Mice through Modulating Immune Balance and Skin Barrier Function
title_fullStr Fermented <i>Morinda citrifolia</i> (Noni) Alleviates DNCB-Induced Atopic Dermatitis in NC/Nga Mice through Modulating Immune Balance and Skin Barrier Function
title_full_unstemmed Fermented <i>Morinda citrifolia</i> (Noni) Alleviates DNCB-Induced Atopic Dermatitis in NC/Nga Mice through Modulating Immune Balance and Skin Barrier Function
title_sort fermented <i>morinda citrifolia</i> (noni) alleviates dncb-induced atopic dermatitis in nc/nga mice through modulating immune balance and skin barrier function
publisher MDPI AG
series Nutrients
issn 2072-6643
publishDate 2020-01-01
description <i>Morinda citrifolia</i>, a fruit generally known as &#8220;Noni&#8221;, has been traditionally used in parts of East Asia to relieve inflammatory diseases. Although several studies using noni have been reported, the effect of fermented <i>Morinda citrifolia</i> (F.NONI) on atopic dermatitis (AD) has not been investigated. Thus, we aimed to investigate the improving effect of F.NONI treatment on AD-like skin lesions and elucidate molecular mechanisms. F.NONI was prepared by the fermentation of noni fruit with probiotics and then extracted. F.NONI was orally administrated to NC/Nga mice to evaluate its therapeutic effect on 2,4-dinitrochlorobenzene (DNCB)-induced AD. Oral administration of F.NONI significantly alleviated AD lesions and symptoms such as dermatitis scores, ear thickness, scratching behavior, epidermal thickness, and infiltration of inflammatory cells (e.g., mast cells and eosinophils). In addition, F.NONI treatment reduced the levels of histamine, IgE and IgG1/IgG2a ratio, thymus and activation regulated chemokine (TARC), and thymic stromal lymphopoietin (TSLP) in serum and beneficially modulated the expressions of Th1, Th2, Th17, and Th22-mediated cytokines in lesioned skin and splenocytes. Furthermore, the expressions of the skin barrier-related proteins including filaggrin (FLG), loricrin (LOR), involucrin (IVL), zonula occludens-1 (ZO-1), and occludin (OCC) were restored by F.NONI treatment. Taken together, these results suggest that F.NONI could be a therapeutic agent to attenuate AD-like skin lesions through modulating the immune balance and skin barrier function.
topic atopic dermatitis
fermented morinda citrifolia
nc/nga
th1
th2
immune balance
skin barrier function
url https://www.mdpi.com/2072-6643/12/1/249
work_keys_str_mv AT sunghokim fermentedimorindacitrifoliainonialleviatesdncbinducedatopicdermatitisinncngamicethroughmodulatingimmunebalanceandskinbarrierfunction
AT geumsuseong fermentedimorindacitrifoliainonialleviatesdncbinducedatopicdermatitisinncngamicethroughmodulatingimmunebalanceandskinbarrierfunction
AT seyoungchoung fermentedimorindacitrifoliainonialleviatesdncbinducedatopicdermatitisinncngamicethroughmodulatingimmunebalanceandskinbarrierfunction
_version_ 1725176319140954112